Nancy Hosken, Ph.D., serves as the Scientific Director for Vaccine Development at PATH since July 2015, overseeing immunology activities in vaccine programs targeting diseases such as Pneumococcus and RSV. As the Owner and Founder of Hosken BioPharma Consulting, LLC from July 2011 to December 2020, Nancy provided guidance on the development of biologics and biotechnology startups. Past roles include Project Manager and Research Scientist at the University of Washington, Associate Director in Immunology at Immune Design, Senior Scientist positions at ZymoGenetics and Corixa Corporation, and a Postdoctoral Fellowship at DNAX Research Institute. Academic credentials include a Ph.D. in Biology (Immunology) from UC San Diego and a Project Management certificate from the University of Washington.
This person is not in any teams
This person is not in any offices